๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Shanghai
Clinical trial register · China

Clinical Trials in Shanghai, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fudan University454 Ruijin Hospital276 Shanghai Zhongshan Hospital163 RenJi Hospital135 Children's Hospital of Fudan University84
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Shanghai

3827 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia
NCT06980155Acute Myeloid Leukemia
Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1
60
Shanghai
2025-05-30
Recruiting
A Study of HDM2005 in Patients With Advanced Solid Tumor
NCT07004296Advanced Solid Tumors
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1
72
Shanghai
2025-05-29
Recruiting
A Phase I Study of HS-20108 in Participants With Advanced Solid Tumors
NCT06936735Advanced Solid Tumor
Hansoh BioMedical R&D Company
Phase 1
502
Shanghai
2025-05-29
Recruiting
JS207 Combined With JS007 as First-line Treatment for Advanced Hepatocellular Carcinoma
NCT06954467Hepatocellular Carcinoma
Shanghai Junshi Bioscience Co., Ltd.
Phase 2
72
Hefei, Beijing, Harbin, Zhengzhou, Changsha, Nanchang, Shenyang, Shanghai
2025-05-29
Recruiting
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
NCT06764615Crohn's Disease, Ulcerative Colitis
Takeda
Phase 2
192
Chongqing, Guangdong, Guangzhou, Shanghai
2025-05-28
Recruiting
Granzyme B-PET: Predicting Immunotherapy Efficacy in TNBC
NCT07705438Triple Negative Breast Cancer, Immune Checkpoint Inhibitor, Granzyme B PET/CT
Fudan University
Observational
30
Shanghai
2025-05-28
Not yet open
Deep Cervical Lymphaticovenous Anastomosis Surgery for Moderate-to-Advanced Dementia Patients
NCT06978946Alzheimer Disease, Lewy Body Dementia (LBD), Frontotemporal Dementia (FTD), Dementia
RenJi Hospital
Not applicable
85
Shanghai
2025-05-28
Recruiting
Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
NCT06780098Lung Neoplasm
Merck Sharp & Dohme LLC
Phase 2
144
Beijing, Chongqing, Fuzhou, Nanning, Zhengzhou, Nanjing, Shanghai
2025-05-28
Recruiting
Phase II Trial of Tunlametinib in NRAS-Mutant Advanced Thyroid Cancer
NCT06970353Radioactive Iodine-refractory, Differentiated Thyroid Cancer With NRAS Mutation, Advanced PDTC or ATC With NRAS Mutation
Fudan University
Phase 2
40
Shanghai
2025-05-27
Recruiting
Safety and Efficacy Evaluation of GC101 Gene Therapy Via Intrathecal (IT) Injectionin the Treatment of Patients With Type 2 Spinal Muscular Atrophy (SMA) - Phase III
NCT06971094SMA - Spinal Muscular Atrophy
GeneCradle Inc
Phase 3
50
Beijing, Shanghai, Shenzhen, Suzhou, Wuhan
2025-05-27
Recruiting
A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Selinexor for the Treatment of R/R NKTCL
NCT06966154Natural Killer/T-cell Lymphoma, Relapsed or Refractory Lymphoma Including ENKL
Fudan University
Phase 1/2
68
Shanghai
2025-05-26
Active, closed
A Study to Assess Safety and Effectiveness of HArmonyCa Lidocaine Injectable Gel for Restoration and/or Creation of Mid-Face Volume in Adult Participants
NCT07032597Mid Face Volume Deficit
AbbVie
Phase 3
252
Beijing, Wuhan, Nanjing, Wuxi, Shanghai, Hangzhou
2025-05-26
Recruiting
A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (B-NHL)
NCT07072169B-cell Non-Hodgkin Lymphoma
Ruijin Hospital
Phase 1
56
Shanghai
2025-05-26
Recruiting
A Study on the Correlation Between Oral Health and Delirium in Surgical Inpatients
NCT06969092Oral Health
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
550
Shanghai
2025-05-25
Recruiting
Dual-target BCMA-CD19 CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration
NCT07003555Relapsed or Refractory Multiple Myeloma (RRMM)
Beijing GoBroad Hospital
Phase 1
18
Shanghai
2025-05-25
Recruiting
Dual-target BCMA-GPRC5D CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration
NCT07003568Relapsed or Refractory Multiple Myeloma (RRMM)
Beijing GoBroad Hospital
Phase 1
18
Shanghai
2025-05-25
Recruiting
A Randomized Controlled Trial of Gabor-Based Perceptual Learning for Adult Amblyopia
NCT07764198Amblyopia, Anisometropia
Jiannan Huang
Not applicable
80
Shanghai
2025-05-25
Recruiting
Study of ZG005 Combined With Gecacitinib in Patients With Advanced Non-Small Cell Lung Cancer
NCT06903377Non-small Cell Lung Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 1/2
50
Shanghai
2025-05-23
Recruiting
GemCis Plus PD-1/PD-L1 Inhibitor in Advanced Biliary Tract Cancer: Efficacy and Immune Microenvironment ๏ผˆBTC-IM-1๏ผ‰
NCT06988592Advanced Biliary Tract Cancer
Fudan University
Observational
100
Shanghai
2025-05-23
Recruiting
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
NCT06901531Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
Astellas Pharma Global Development, Inc.
Phase 3
500
Hefei, Fuzhou, Guangzhou, Harbin, Zhenngzhou, Wuhan, Xining, Shanghai
2025-05-22
Active, closed
This is a Multi-centre, Multi-drug, Platform Study in Chinese Participants Living With Obesity / Overweight
NCT07017179Obesity/Overweight
AstraZeneca
Phase 2
14
Jinan, Nanjing, Shanghai
2025-05-20
Recruiting
A Cohort Study on ctDNA MRD in Neoadjuvant Therapy for Pancreatic Cancer
NCT07080021Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Adenocarcinoma
Ruijin Hospital
Observational
119
Shanghai
2025-05-20
Recruiting
A Phase I Study of SIM0686 in Participants With Locally Advanced/Metastatic Solid Tumors
NCT07050459Locally Advanced Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
220
Beijing, Haerbin, Zhengzhou, Changsha, Nanjing, Jinan, Shanghai, Chengdu
2025-05-20
Recruiting
IndObufen Versus asPirin After Coronary Drug-eluting Stent implantaTION in Elderly Patients With Acute Coronary Syndrome
NCT06451198Coronary Artery Disease, Antiplatelet Drugs
Shanghai Zhongshan Hospital
Phase 4
2,846
Shanghai
2025-05-19
Recruiting
A Phase I Clinical Study of a Single Dose of KLA480
NCT07030790Healthy Participants
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
Phase 1
20
Shanghai
2025-05-17
Active, closed
Myopia Progression With Freeform Myopia Control Spectacles
NCT06927388Myopia, Progressive
Shanghai Eye Disease Prevention and Treatment Center
Not applicable
180
Shanghai
2025-05-17
Not yet open
A Multicenter, Randomized, Double-blind, Placebo-controlled Parallel-group Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of XH-S004 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis
NCT06981091Non-Cystic Fibrosis Bronchiectasis
S-INFINITY Pharmaceuticals Co., Ltd
Phase 2
231
Shanghai
2025-05-16
Recruiting
A Study of SH009 Injection in Patients With Advanced Solid Tumors.
NCT07390838Liver Cancer (Locally Advanced or Metastatic), Lung Cancer (NSCLC), Head and Neck Cancer Squamous Cell Carcinoma, Breast Cancer (Locally Advanced or Metastatic)
Nanjing Sanhome Pharmaceutical, Co., Ltd.
Phase 1
150
Shanghai
2025-05-16
Recruiting
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
NCT06947993Atopic Dermatitis
Novartis Pharmaceuticals
Phase 2
224
Guangzhou, Shantou, Changsha, Changchun, Hangzhou, Beijing, Shanghai
2025-05-16
Not yet open
Endoscopic Cryoablation Combined With PD-1 in Advanced Gastric Cancer
NCT06759233Gastric Cancer
Zhongguang Luo, MD
Phase 2
15
Shanghai
2025-05-15
Recruiting
A Study of the Pharmacokinetics and Safety of Single-dose Inhaled RJ026 in Healthy Volunteers and Patients With Interstitial Lung Disease
NCT06992661Interstitial Lung Disease (ILD), Healthy Volunteers
Ruijin Hospital
Phase 1
84
Shanghai
2025-05-15
Not yet open
Neoadjuvant Chemotherapy in High - Risk Upper Tract Urothelial Carcinoma
NCT06927128UTUC, NAC
Changhai Hospital
Phase 2
45
Shanghai
2025-05-15
Recruiting
A Study of Nimotuzumab Plus Adebrelimab With Chemotherapy in Cisplatin-Ineligible Patients With Head And Neck Squamous Cell Carcinoma
NCT07105592Head and Neck Squamous Cell Carcinoma
Fudan University
Phase 1/2
68
Shanghai
2025-05-13
Recruiting
A Study of ZL-1310 in Participants With Selected Solid Tumors
NCT06885281Solid Tumors
Zai Lab (Shanghai) Co., Ltd.
Phase 1/2
166
Beijing, Xiamen, Guangzhou, Harbin, Changsha, Changchun, Shanghai
2025-05-12
Recruiting
Transbronchial MWA for Pulmonary Tumors
NCT06969014Lung Cancer
Shanghai Chest Hospital
Not applicable
15
Shanghai
2025-05-12
Recruiting
Induction Chemotherapy Combined With Tislelizumab for Locally Advanced Squamous Cell Carcinoma of the External Auditory Canal
NCT07370337Squamous Cell Carcinoma of External Auditory Canal, Locally Advanced Tumor
Eye & ENT Hospital of Fudan University
Phase 2
50
Shanghai
2025-05-12
Active, closed
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-031/LIGHTRAY EXTENSION)
NCT06925750Pulmonary Arterial Hypertension
Merck Sharp & Dohme LLC
Phase 2
130
Guangzhou, Changsha, Shanghai, Kunming
2025-05-12
Recruiting
A Phase I Clinical Trial of CAR-T Cells for Advanced Gynecological Solid Tumors
NCT06904131Gynecological Solid Tumors
Obstetrics & Gynecology Hospital of Fudan University
Not applicable
20
Shanghai
2025-05-11
Recruiting
Research on Early Prediction Model of Ischemic Cerebrovascular Disease Based on Artificial Intelligence Technology.
NCT06978348Ischemic Cerebrovascular Disease, Artificial Intelligence, Prediction Model
Shanghai Jiao Tong University School of Medicine
Observational
244,296
Shanghai
2025-05-10
Active, closed
Realistic in Generation of HEp-2 Cell Images Using Latent Diffusion Models: a Multi-center Visual Turing Test
NCT06542783Autoimmune / Connective Tissue Diseases, Anti-Nuclear Antibody, Visual Turing Tests, Artifical Intelligence
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
300
Shanghai
2025-05-10
Recruiting
A Study of MHB036C Combined With Anti-tumor Therapies in Patients With Advanced Lung Cancer
NCT07229599Advanced Lung Cancer
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 1/2
300
Shanghai
2025-05-09
Recruiting
Study on Predicting Response to Standard First-Line Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Using ctDNA Combined With PET
NCT07070648Diffuse Large B-Cell Lymphoma, DLBCL
Fudan University
Observational
300
Shanghai
2025-05-09
Recruiting
Evaluation of the Efficacy and Safety of Polatuzumab Vedotin Combined With Rituximab, Gemcitabine, and Oxaliplatin (Pola-R-GemOx) as Salvage Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients Ineligible for Autologous Transplantation
NCT07001540Diffuse Large B-Cell Lymphoma
Fudan University
Phase 2
130
Shanghai
2025-05-08
Active, closed
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BMS-986489 in Chinese Participants With Relapsed/Refractory Small Cell Lung Cancer
NCT06799286Small Cell Lung Carcinoma
Bristol-Myers Squibb
Phase 1
10
Beijing, Jinan, Linyi, Hangzhou, Shanghai
2025-05-07
Recruiting
China Post-approval Commitment (PAC) Study of Avalglucosidase Alfa in Participants With IOPD
NCT06666413Glycogen Storage Disease Type II, Pompe's Disease
Genzyme, a Sanofi Company
Phase 4
13
Shanghai
2025-05-07
Recruiting
HS-10502 Combination Treatment in Patients With Advanced Solid Tumors
NCT06769425Recurrent Ovarian Cancer, HER2-negative, Advanced Breast Cancer, TNBC
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1
157
Shanghai
2025-05-07
Recruiting
A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
NCT06952699Narcolepsy Type 2
Takeda
Phase 2
88
Beijing, Guangzhou, Changchun, Shanghai
2025-05-06
Active, closed
A Randomized Controlled Trial of Robotic Support for Enhanced Later Life (RoSELL)
NCT07102017Loneliness, Well-Being, Psychological, Depression - Major Depressive Disorder
Shanghai Jiao Tong University School of Medicine
Not applicable
90
Shanghai
2025-05-06
Not yet open
Electronic Blood Pressure Monitor for Atrial Fibrillation Detection
NCT06931288Atrial Fibrillation (AF)
Shanghai Jiao Tong University School of Medicine
Not applicable
20,000
Shanghai
2025-05-06
Not yet open
The Palliative Effect of TENS-WAA on 'Capsaicin/Heat' Induced Acute Lower Back Pain: a Self-controlled Clinical Study
NCT06944665Acute Low Back Pain
Xiaonan Huang
Not applicable
30
Shanghai
2025-05-05
Recruiting
Bovine Reinforcement in Stomach, Colorectal and Lung Operation
NCT06968221Rectal Cancer Stage III, Lung Cancer Stage III
Shanghai Cingularbio Co. Ltd
Phase 3
172
Shanghai
2025-05-01
Not yet open
A Study of SHR-1826 Monotherapy or in Combination With Immunotherapy in the Treatment of Advanced Hepatocellular Cancer
NCT06935175Hepatocellular Cancer
Shanghai Zhongshan Hospital
Phase 2
53
Shanghai
2025-05-01
Recruiting
PULSAR Radiotherapy Plus Anti-PD-1 Therapy in Metastatic Abdominopelvic Tumors
NCT07383857Cancer
Zhen Zhang
Not applicable
103
Shanghai
2025-05-01
Recruiting
Sleep Disorders and Tumor Immune Microenvironment
NCT06941948Impact of Sleep Disorders on Tumor Immune Microenvironment and Clinical Outcomes in Lung Cancer
Shanghai Zhongshan Hospital
Observational
400
Shanghai
2025-05-01
Not yet open
Oncolytic Virus H101 Combined With Lenvatinib Plus Toripalimab Compared With FOLFOX in Patients With Advanced Biliary Tract Cancer (OPTIONS-06)
NCT06919848Biliary Tract Cancer (BTC)
Fudan University
Phase 2
74
Shanghai
2025-05-01
Not yet open
Active Surveillance for Limited GGNs
NCT06394037Lung Ground-glass Opacities, Active Surveillance
Fudan University
Observational
387
Shanghai
2025-05-01
By invitation
Gemcitabine and Nab-Paclitaxel Combined With Iparomlimab and Tuvorilimab for Advanced Gallbladder Cancer
NCT07310069Gallbladder Cancer Unresectable
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2
44
Shanghai
2025-05-01
Recruiting
An Observational Study of Inflammatory Bowel Disease (IBD) Patients With Non-alcoholic Fatty Liver Disease (NAFLD)
NCT06939569Inflammatory Bowel Disease (IBD), Metabolic Dysfunction Associated Fatty Liver Disease
Shanghai East Hospital
Observational
337
Shanghai
2025-05-01
Recruiting
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
NCT06916806Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathies, Rheumatoid Arthritis
AstraZeneca
Phase 1
72
Beijing, Shanghai, Wuhan, Zhengzhou
2025-05-01
Recruiting
Efficacy of Triple-daily 15mA tACS on Adolescent NSSI
NCT06919432Self-Injurious Behavior
Shanghai Mental Health Center
Not applicable
66
Shanghai
2025-05-01
Recruiting
HiSCs in the Treatment of Rheumatoid Arthritis
NCT06947746Rheumatoid Arthritis (RA)
Shanghai Changzheng Hospital
Not applicable
15
Shanghai
2025-05-01
Not yet open
A Randomized Controlled Study of Endoscopic Cryoablation Combined With PD-1 Inhibitor for Maintenance Therapy in Advanced Gastric Cancer
NCT06957977Gastric Cancer, Cryoballoon Ablation
Zhongguang Luo, MD
Phase 2
42
Shanghai
2025-05-01
Not yet open
A Phase 1, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03017
NCT06980207Hallucinations and Delusions Associated With Alzheimer's Disease Psychosis, Hallucinations and Delusions Associated With Parkinson Disease Psychosis, Negative Symptoms of Schizophrenia
Luye Pharma Group Ltd.
Phase 1
40
Shanghai
2025-05
Not yet open
Early Diagnosis and Recurrence Monitoring of Colorectal Cancer
NCT06991452Colorectal Cancer
Huashan Hospital
Observational
1,200
Shanghai
2025-05
Not yet open
Safety and Efficacy Study of Single-port Robotic Versus Multi-port Robotic Radical Rectal Cancer Surgery
NCT06943690Rectal Cancer, Surgery
Ruijin Hospital
Not applicable
212
Luoyang, Jinan, Shanghai, Wenzhou
2025-05
Not yet open
Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel Injection as First-Line Therapy of High-Risk Large B-Cell Lymphoma
NCT06935136CAR-T Cell Therapy, High-risk Large B-cell Lymphoma (LBCL)
Ruijin Hospital
Not applicable
60
Shanghai
2025-04-30
Recruiting
Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection to Treat Moderate to Severe Glabellar Lines
NCT06937944Moderate to Severe Glabellar Lines
JHM BioPharma (Tonghua) Co. , Ltd.
Phase 3
669
Beijing, Chongqing, Guangzhou, Shijiazhuang, Changsha, Xuzhou, Shanghai, Xianyang
2025-04-30
Recruiting
Early Initiated Ambulance-delivered Levetiracetam and Headposition in Hyper-acute Stroke Trial
NCT06773364Suspected Stroke
Shanghai East Hospital
Phase 3
2,423
Suzhou, Shanghai
2025-04-30
Recruiting
The Application of Electrical Stimulation in Postoperative Pain Management of Thyroid Surgery
NCT06931743Thyroid Surgery, Electrical Stimulation, Thyroid Carcinoma
Xiaonan Huang
Not applicable
668
Shanghai
2025-04-30
Recruiting
A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.
NCT06907043Advanced Solid Tumors
Eikon Therapeutics
Phase 1/2
130
Chongqing, Jinan, Shanghai
2025-04-30
Recruiting
FGF19 Overexpression Combination Unified Study in HCC-19
NCT06978933HCC - Hepatocellular Carcinoma
RenJi Hospital
Phase 2
42
Shanghai
2025-04-30
Recruiting
Comparison of Drainage Methods in Minimally Invasive Esophagectomy (DEMURE๏ผ‰
NCT07004634Esophageal Cancer, Drainage/Methods, Postoperative Pain
Ruijin Hospital
Not applicable
75
Shanghai
2025-04-30
Recruiting
Mechanisms of Deep Transcranial Magnetic Stimulation in Enhancing Cognitive-Behavioral Therapy for Anorexia Nervosa
NCT06942858Feeding and Eating Disorders
Shanghai Mental Health Center
Not applicable
110
Shanghai
2025-04-30
Recruiting
Single Plastic Stent Vs. Fully Covered Self-Expanding Metal Stent on Benign Biliary Stricture Secondary to Chronic Pancreatitis
NCT06655051Chronic Pancreatitis, Benign Biliary Stricture
Changhai Hospital
Not applicable
134
Shanghai
2025-04-30
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
NCT06884618Neoplasms
Hoffmann-La Roche
Phase 1
405
Guangzhou, Shanghai, Wuhan
2025-04-30
Active, closed
JS111 in Patients With Advanced NSCLC Harboring EGFR Mutations
NCT06940401NSCLC
Suzhou Junjing BioSciences Co., Ltd.
Phase 1/2
44
Shanghai
2025-04-30
Recruiting
High-Risk Transcriptome Molecular Prediction Study of MASH-Associated Colorectal Polyps
NCT07463287MASH - Metabolic Dysfunction-Associated Steatohepatitis
Shanghai East Hospital
Observational
100
Shanghai
2025-04-30
Recruiting
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
NCT06813911Atherosclerotic Cardiovascular Disease (ASCVD)
Novartis Pharmaceuticals
Phase 3
340
Yinchuan, Jining, Xian, Beijing, Shanghai
2025-04-30
Recruiting
TRanscAtheter TreatMent of PurE Aortic Regurgitation With VitaFlow Liberty System
NCT06818084AORTIC VALVE DISEASES, Aortic Regurgitation, Transcatheter Aortic Valve Replacement (TAVR)
Ruijin Hospital
Phase 4
120
Shanghai
2025-04-29
Active, closed
Study for AZD4360 in Participants With Advanced Solid Tumours
NCT06921928Gastric Cancer, Gastroesophageal Junction Cancer, Biliary Tract Cancer, Pancreatic Ductal Adenocarcinoma
AstraZeneca
Phase 1/2
31
Beijing, Chengdu, Shanghai, Wuhan
2025-04-29
Active, closed
Itchy Scalp Biomarkers Exploration
NCT07805031Itchy Scalp, Pruritus, Dandruff
L'Oreal
Observational
132
Shanghai
2025-04-28
Recruiting
Metformin in Post Chronic Pancreatitis Diabetes Mellitus
NCT06937294Chronic Pancreatitis
Changhai Hospital
Phase 4
58
Shanghai
2025-04-28
Not yet open
Comparing Neoadjuvant Chemotherapy Combined With PD-1 Inhibitor Versus Neoadjuvant Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Carcinoma
NCT06957938Laryngeal Carcinoma, Hypopharyngeal Carcinoma
Fudan University
Phase 3
168
Shanghai
2025-04-28
Recruiting
Prevalence and Risk Factors of Hyperkalemia in Non-Dialysis Chronic Kidney Disease Patients in Community
NCT06940414Hyperkalemia, Chronic Kidney Disease(CKD)
Xiujuan Zang
Observational
1,890
Shanghai
2025-04-28
Recruiting
Clinical Safety and Efficacy of Flow-diverter in the Treatment of Intracranial Aneurysms
NCT06943729Flow Diverter
Huashan Hospital
Observational
523
Shanghai
2025-04-27
Recruiting
A Phase I Clinical Study of SSS59 Monotherapy in Patients With Advanced Malignant Tumors
NCT06944444Malignant Tumors
Shenyang Sunshine Pharmaceutical Co., LTD.
Phase 1
154
Shanghai
2025-04-27
Recruiting
Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC)
NCT06943235Limited Stage Small Cell Lung Cancer
Fudan University
Phase 2
60
Shanghai
2025-04-25
Recruiting
Clinical Study on the Treatment of MIBC Patients With SHR-A2102 Injection Combined With Adebrelimab (SHR-1316)
NCT06879145Muscular Invasive Bladder Cancer (MIBC)
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 2/3
840
Shanghai
2025-04-25
Recruiting
Study on Multi-Modality Models of Cardiac Function in Healthy Individuals
NCT06952673Healthy Volunteers Only
Shanghai Ruiwei Digital Technology Co. Ltd.
Not applicable
270
Shanghai
2025-04-25
Recruiting
Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors
NCT06414460Locally Advanced/Metastatic Solid Tumors
InSilico Medicine Hong Kong Limited
Phase 1/2
146
Beijing, Guangzhou, Nanjing, Shanghai
2025-04-25
Active, closed
A Study to Evaluate the Efficacy and Safety of IBI302 inSubjects With Diabetic Macular Edema๏ผˆDME๏ผ‰
NCT06908876Diabetic Macular Oedema
Innovent Biologics Technology Limited (Shanghai R&D Center)
Phase 2
150
Shanghai
2025-04-24
Recruiting
A Study of BR111 in Patients With Advanced Malignancies
NCT06937957Advanced Malignancies
BioRay Pharmaceutical Co., Ltd.
Phase 1
166
Shanghai
2025-04-24
By invitation
A Real-world Study of Deucravacitinib in the Treatment of Moderate to Severe Plaque Psoriasis With Eczematous Features
NCT06999941Psoriasis, Eczema, JAK Inhibitor
Xi Tan
Observational
50
Shanghai
2025-04-24
Recruiting
Sapien 3 Transcatheter Aortic Valve Replacement in Young Aortic Valve Stenosis Patients From China
NCT06830499AORTIC VALVE DISEASES, Bicuspid Aortic Valve (BAV)
Xijing Hospital
Observational
450
Xi'an, Chengdu, Beijing, Shanghai
2025-04-24
Recruiting
A Phase I Study of SIM0388 in Participants With Malignant Ascites.
NCT07007988Malignant Ascites
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
50
Shanghai
2025-04-24
Recruiting
A Trial of HRS-6768 in Patients With Advanced Solid Tumors
NCT06925581Advanced Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2
84
Beijing, Shanghai
2025-04-24
Recruiting
A Phase 2 Study Evaluating the Safety and Efficacy of JS207 With or Without JS015 in Combination With Chemotherapy in Patients With Colorectal Cancer
NCT06885385Advanced Colorectal Cancer
Shanghai Junshi Bioscience Co., Ltd.
Phase 2
60
Beijing, Shanghai
2025-04-23
Recruiting
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
NCT06827236Locally Advanced Breast Cancer, Unresectable Breast Carcinoma, Metastatic Breast Cancer
BioNTech SE
Phase 1/2
380
Bengbu, Changchun, Chengdu, Chongqing, Huizhou, Nanning, Shanghai, Xi'an
2025-04-23
By invitation
Intrapatient Comparison of STN and GPi tTIS in PD
NCT07018388Parkinson Disease
Ruijin Hospital
Not applicable
100
Shanghai
2025-04-23
Recruiting
A Phase II Clinical Study to Evaluate HLX43 in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
NCT06857279Carcinoma of Head and/or Neck
Shanghai Henlius Biotech
Phase 2
167
Jinan, Shanghai
2025-04-22
Rows per page Showing 1501–1600 of 3827
Previous 14 15 16 17 18 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/shanghai?page=16

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 3,827 of those studies with a site in Shanghai.

How many clinical trials are recruiting in Shanghai?

2,393 of the 3,827 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 737 have not yet opened recruitment, 588 are active but closed to new participants, and 109 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.